Publications by Medical Specialty - Oncology
These publications were authored or co-authored by Quest Diagnostics staff.
- Cardiology
- Clinical and Lab healthcare professionals
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family medicine practitioners
- Gastroenterology
- General Health and Wellness
- Genetics
- Geriatrics/Age Management
- Health Information Technology
- Hematology/Hemostasis/Thrombosis
- Infectious Disease
- Internal Medicine
- IVF
- Laboratory
- Lipidology
- Nephrology
- Neurology
- Nurse practitioners
- Oncology
- Other
- Pathology
- Pathology, Anatomic
- Pathology, Laboratory Medicine
- PCPs
- Pediatrics
- Physician assistants
- Prescription Drug Monitoring
- Psychiatrists
- Pulmonology
- Rheumatology/Immunology/Allergy
- Sports Medicine
- Toxicology/Pain Management
- Transplant
- Urology
- Women's Health/OB/GYN
Next-Generation Sequencing in High-Sensitive Detection of Mutations in Tumors: Challenges, Advances and Applications
Authors: Singh RR
J Mol Diagn. 2020 May 29:S1525-1578(20)30330-5. doi: 10.1016/j.jmoldx.2020.04.213.
Xanthogranulomatous Epithelial Tumor: Report of 6 Cases of a Novel, Potentially Deceptive Lesion With a Predilection for Young Women
Authors: Fritchie KJ, Torres-Mora J, Inwards C, Thway K, Vaiyapuri S, Jackson R, Minn K, Halling K, Arndt C, Houdek MT, Wenger DE, Curry R, Thirumala S, Fisher C, Davila J, Folpe AL.
Mod Pathol. 2020 May 15. doi: 10.1038/s41379-020-0562-8. Online ahead of print.
Specialties: Dermatology, Oncology
Disclaimer: One or more of the authors of this publication were employed at the time by AmeriPath, a subsidiary of Quest Diagnostics.
The Evolving Clinical Testing Landscape of Genomic Aberrations in Solid Tumors and Hematological Malignancies - Insights From Evidence-Based Reviews for B-ALL and Breast, Brain, and Renal Cell Neoplasia
Authors: Miron PM, Fang M.
Cancer Genet. 2020 Apr 28;244:60-61. doi: 10.1016/j.cancergen.2020.04.001.
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers into breast cancer clinical trials and daily practice.
Authors: Gonzalez-Ericsson PI, Stovgaard ES, Sua LF, Reisenbichler E, Kos Z, Carter JM, Michiels S, Le Quesne J, Nielsen TO, Laenkholm AV, Fox SB, Adam J, Bartlett JM, Rimm DL, Quinn C, Peeters D, Dieci MV, Vincent-Salomon A, Cree I, Hida AI, Balko JM, Haynes HR, Frahm I, Acosta-Haab G, Balancin M, Bellolio E, Yang W, Kirtani P, Sugie T, Ehinger A, Castaneda CA, Kok M, McArthur H, Siziopikou K, Badve S, Fineberg S, Gown A, Viale G, Schnitt SJ, Pruneri G, Penault-Llorca F, Hewitt S, Thompson EA, Allison KH, Symmans WF, Bellizzi AM, Brogi E, Moore DA, Larsimont D, Dillon DA, Lazar A, Lien H, Goetz MP, Broeckx G, El Bairi K, Harbeck N, Cimino-Mathews A, Sotiriou C, Adams S, Liu SW, Loibl S, Chen IC, Lakhani SR, Juco JW, Denkert C, Blackley EF, Demaria S, Leon-Ferre R, Gluz O, Zardavas D, Emancipator K, Ely S, Loi S, Salgado R, Sanders M; International Immuno-Oncology Biomarker Working Group.
J Pathol. 2020 Apr;250:667-684. doi: 10.1002/path.5406. Epub 2020 Apr 9.
Specialties: Oncology
Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours.
Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky JB, Shi CJ, Giannico GA.
Histopathology. 2020 Mar;76:550-559. doi: 10.1111/his.14012. Epub 2020 Jan 24.
Specialties: Oncology
Disclaimer: One or more of the authors of this publication were employed at the time by , a subsidiary of Quest Diagnostics.
Salivary ghost cell carcinoma: case report and proposal of a new entity.
Authors: Ihrler S, Mollenhauer M, Weitmayr B, Haas CJ.
Virchows Arch. 2020 Mar;476(3):465-468.
Specialties: Dermatology, Oncology
Disclaimer: One or more of the authors of this publication were employed at the time by DermPath, a subsidiary of Quest Diagnostics.
Development and Validation of a 34-Gene Inherited Cancer Predisposition Panel Using Next-Generation Sequencing
Authors: Rosenthal SH, Sun W, Zhang K, Liu Y, Nguyen Q, Gerasimova A, Nery C, Cheng L, Castonguay C, Hiller E, Li J, Elzinga C, Wolfson D, Smolgovsky A, Chen R, Buller-Burckle A, Catanese J, Grupe A, Lacbawan F,Owen R
BioMed Res Int. 2020, https://doi.org/10.1155/2020/3289023 [Epub ahead of print]
Specialties: Oncology
Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia.
Authors: He RR, Nayer Z, Hogan M, Cuevo RS, Woodward K, Heyer D, Curtis CA, Peterson JF.
Case Rep Hematol. 2019 Dec 7;2019:7394619.
Specialties: Oncology
Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia.
Authors: Shmukler BE, Rivera A, Bhargava P, Nishimura K, Kim EH, Hsu A, Wohlgemuth JG, Morton J, Snyder LM, De Franceschi L, Rust MB, Hubner CA, Brugnara C, Alper SL.
Blood Cells Mol Dis. 2019 Nov 25;81:102389.
Specialties: Oncology
SATB2 Protein Expression by Immunohistochemistry is a Sensitive and Specific Marker of Appendiceal and Rectosigmoid Well Differentiated Neuroendocrine Tumors.
Authors: Hoskoppal D, Epstein JI, Gown AM, Arnold Egloff SA, Gordetsky J, Shi CC, Giannico GA.
Histopathology. 2019 Oct 9. doi: 10.1111/his.14012. [Epub ahead of print]
Specialties: Oncology
